Eva Bubanská

414 total citations
13 papers, 110 citations indexed

About

Eva Bubanská is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Eva Bubanská has authored 13 papers receiving a total of 110 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 6 papers in Hematology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eva Bubanská's work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Eva Bubanská is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Eva Bubanská collaborates with scholars based in Slovakia, Czechia and Poland. Eva Bubanská's co-authors include Cáp J, J. Trupl, V. Krčméry, Lucia Dora Notarangelo, Smith Rjh, Laura Dotta, Marcella Visentini, Fulvio Porta, Massimo Fiorilli and Vassilios Lougaris and has published in prestigious journals such as Seminars in Thrombosis and Hemostasis, Blood Cells Molecules and Diseases and The Journal of Allergy and Clinical Immunology In Practice.

In The Last Decade

Eva Bubanská

12 papers receiving 107 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Bubanská Slovakia 7 34 30 28 27 24 13 110
Malgorzata McMasters United States 7 59 1.7× 35 1.2× 13 0.5× 25 0.9× 21 0.9× 18 120
Clémence Mediavilla France 8 88 2.6× 31 1.0× 26 0.9× 27 1.0× 15 0.6× 18 137
Ibraheem Abosoudah Saudi Arabia 5 14 0.4× 39 1.3× 60 2.1× 28 1.0× 25 1.0× 12 125
Paibel Aguayo‐Hiraldo United States 8 23 0.7× 45 1.5× 49 1.8× 49 1.8× 11 0.5× 23 135
Machiko Kusuda Japan 8 82 2.4× 56 1.9× 29 1.0× 37 1.4× 12 0.5× 38 152
Isabel Cano Spain 8 80 2.4× 45 1.5× 17 0.6× 27 1.0× 15 0.6× 21 154
Kevin Jestice United Kingdom 6 85 2.5× 36 1.2× 29 1.0× 46 1.7× 13 0.5× 8 178
Damianos Sotiropoulos Greece 8 92 2.7× 46 1.5× 37 1.3× 17 0.6× 50 2.1× 28 172
Firoozeh Sahebi United States 7 90 2.6× 29 1.0× 34 1.2× 13 0.5× 17 0.7× 14 120
Dai Keino Japan 7 30 0.9× 30 1.0× 13 0.5× 14 0.5× 27 1.1× 35 117

Countries citing papers authored by Eva Bubanská

Since Specialization
Citations

This map shows the geographic impact of Eva Bubanská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Bubanská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Bubanská more than expected).

Fields of papers citing papers by Eva Bubanská

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Bubanská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Bubanská. The network helps show where Eva Bubanská may publish in the future.

Co-authorship network of co-authors of Eva Bubanská

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Bubanská. A scholar is included among the top collaborators of Eva Bubanská based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Bubanská. Eva Bubanská is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Boďová, Ivana, et al.. (2019). Diagnosis and treatment of juvenile myelomonocytic leukemia in Slovak Republic: novel approache. Neoplasma. 66(5). 818–824. 4 indexed citations
2.
Vojta, Petr, Monika Horváthová, Jaroslav Čermák, et al.. (2019). Czech and Slovak Diamond-Blackfan Anemia (DBA) Registry update: Clinical data and novel causative genetic lesions. Blood Cells Molecules and Diseases. 81. 102380–102380. 10 indexed citations
3.
Dotta, Laura, Lucia Dora Notarangelo, Daniele Moratto, et al.. (2019). Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies. The Journal of Allergy and Clinical Immunology In Practice. 7(5). 1568–1577. 34 indexed citations
4.
Bátorová, Angelika, et al.. (2016). Inhibitors in Severe Hemophilia A: 25-Year Experience in Slovakia. Seminars in Thrombosis and Hemostasis. 42(5). 550–562. 11 indexed citations
5.
Štěrba, Jaroslav, et al.. (2015). Capizzi methotrexate with BFM backbone without craniospinalirradiation is effective treatment for pediatric lymphoblasticlymphoma: results from 5 countries with I-BFM LL 09 protocol. 3 indexed citations
8.
Kolenová, Alexandra, Eva Bubanská, Stanislava Hederová, et al.. (2012). Development of treatment and clinical results in childhood acute myeloid leukemia in the Slovak Republic. memo - Magazine of European Medical Oncology. 6(1). 46–53. 3 indexed citations
9.
Kaiserová, E, et al.. (2011). Results of acute lymphoblastic leukemia treatment in children in the Slovak Republic. memo - Magazine of European Medical Oncology. 4(3). 190–195. 6 indexed citations
11.
Urbanová, D, et al.. (2010). Heart transplant in a childhood leukemia survivor: a case report.. PubMed. 8(1). 79–81. 3 indexed citations
13.
Michalová, K, Oliver Bartsch, Jan Starý, et al.. (1993). Partial trisomy of 3q detected by chromosome painting in a case of juvenile chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics. 71(1). 67–70. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026